Global Health Information & Medical Research Institute
Virus/Disease:
AIDS/HIV
Product:
High Potency Silvicidal also referred to as "CellStat HIV"
Important:
Many dishonest dietary supplement companies have been referencing these test results for products they refer to as "Mild Silver Protein" (MSP), a classification of liquids. They attempt to make consumers believe this classification of substances had produced these test results (which is ridiculous in itself, similar to advertising, "laxative has clinically proven effective against side effects caused by X, view the trials").
These clinical tests and trials only apply to Silvicidal. Silvicidal IS a silver-based substance which was believed to be classified as a MSP. Silvicidal is NOT an MSP, and should no longer be associated with that classification. Silvicidal is an elixir containing 99.99% pure Ag compounds held in a specific position by a proprietary liquid developed by DEDI. We ask all consumers to remain on the alert for scam-artists and to report them immediately.
In Vivo:
Two trials were conducted with two individuals who had the HIV virus. The names and social security numbers of these individuals will be released on a need to know basis, as a result they will be referred to as patient 251 and 252.
In Vivo - Patient 251:
Patient 251 had a viral load over the measurable scale at the time (somewhere over 750,000). After receiving a single infusion of high potency Silvicidal (given the name CellStat HIV) his viral load dropped from over 750,000 to 39,0333 and his T-Cell count tripled. Patient 251 agreed that he should have a 2nd infusion of the CellStat HIV, to see if it would completely kill the virus and cure him. There were many attempts to contact patient 251 when it was around the time for his second infusion. He could not be located. Despite the fact that we did not find out if Silvicidal would eliminate the virus, this trial in many eyes was a full success. No other products were used during this trial and no adverse side effects were noted.
In Vivo - Patient 252:
Patient 252 had a viral load above 100,000 with the HIV related viruses Herpes and Hepatitis B. He was given the same protocol as patient 251. At the beginning of the trial this patient had an outbreak of Herpes and refused to change his lifestyle. Within 30 days of the High Potency Silvicidal infusion, his viral load dropped 65% and then started to increase. The consensus was that the CellStat HIV could not kill off HIV, herpes and Hepatitis B all at the same time with one major infusion. No side effects were noted. Patient 252 was feeling so well he took on two jobs and showed no outward signs of HIV. A decision to do a second infusion was made. He was sent to his medical doctor for a full check up prior to the second infusion. His doctor reported no symptoms of HIV. Patient 252 could not be located to receive the second infusion. Due to the fact that this patient refused to change his lifestyle and could have been re-infected at any time, he was going to be terminated from the trial. The patient believed he was cured of HIV even though he was advised there were no such indications.
In Vitro:
Two tests conducted against the HIV virus, not in humans (in vitro), have been conducted. The doctor/professor at Temple University addressed the trials to the president of Discovery Experimental & Development Inc., James Kimball.
In Vitro - Test 1:
Test 1 showed Silvicidal had an effect on the HIV virus, however, because the Silvicidal was formulated into very low concentrates, the HIV virus was not inhibited. This test reflected that Silvicidal was killing the HIV virus and it's effect was dependant upon it's concentration.
In Vitro - Test 2:
Because of Test 1 results, DEDI provided much a much higher series of Silvicidal concentrates for Test 2. At 1000 ppm (particles per million) the Silvicidal killed the virus after being exposed to it for one hour.